Marie-Claude Morice - Concepedia

Author

Marie-Claude Morice

Also Known As

A. Mebaaza, David Kandzari, M C Morice, M Morice, M-C Morice, M. C. Morice, M.-C. Morice, M.C Morice, M.C. Morice, Marie-Claude Morice

142

Publications

20.7K

Citations

H-Index

Concepts

All Affiliations

Institut Cardiovasculaire Paris Sud Erasmus University Rotterdam Erasmus MC Hôpital Privé Jacques Cartier San Raffaele University of Rome

About

Marie-Claude Morice is an author at Institut Cardiovasculaire Paris Sud specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	50	8.7K
2	Public Health	12	13	3K
3	Health Sciences	5	5	581
4	Language Studies	1	1	18
5	Biomedical Engineering	1	1	30

Marie-Claude Morice

Publications

17K

Citations

H-Index

Page 1

	Year	Citations
The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. Georgios Sianos, Marie‐Angèle Morel, Arie Pieter Kappetein, PubMed Cardiac AnaesthesiaAngiographic ToolSouthampton General HospitalCoronary Artery DiseasePublic Health	2005	2.3K
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial Friedrich W. Mohr, Marie-Claude Morice, A. Pieter Kappetein, The Lancet Cardiac SurgeryPercutaneous Coronary InterventionEndovascular TechniqueCardiovascular DiseaseClinical Syntax Trial	2013	1.8K
Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents Gregg W. Stone, Jeffrey W. Moses, Stephen G. Ellis, New England Journal of Medicine	2007	1.6K
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease Gregg W. Stone, Joseph F. Sabik, Patrick W. Serruys, New England Journal of Medicine	2016	1K
Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II Vasim Farooq, David van Klaveren, Ewout W. Steyerberg, The Lancet Cardiac SurgeryPercutaneous Coronary InterventionCardiovascular DiseaseClinical Decision-makingMedicine	2013	813
Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial Marie-Claude Morice, Patrick W. Serruys, A. Pieter Kappetein, Circulation	2010	640
Assessment of the SYNTAX score in the Syntax study Patrick Serruys, Yoshinobu Onuma, Scot Garg, EuroIntervention	2009	635
Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial A. Pieter Kappetein, Ted Feldman, Michael J. Mack, European Heart Journal	2011	562
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk Philip Urban, Roxana Mehran, Róisín Colleran, European Heart Journal	2019	540
Five-Year Outcomes in Patients With Left Main Disease Treated With Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Trial Marie-Claude Morice, Patrick W. Serruys, A. Pieter Kappetein, Circulation	2014	526

Page 1